Literature DB >> 22707919

Production of CGMP-Grade Lentiviral Vectors.

Lara J Ausubel, Christine Hall, Anupriya Sharma, Rebecca Shakeley, Patricia Lopez, Valerie Quezada, Sylvana Couture, Kenneth Laderman, Ross McMahon, Patricia Huang, David Hsu, Larry Couture.   

Abstract

Entities:  

Year:  2012        PMID： 22707919      PMCID： PMC3374843     

Source DB:  PubMed          Journal:  Bioprocess Int        ISSN： 1542-6319


× No keyword cloud information.
  29 in total

1.  A stable system for the high-titer production of multiply attenuated lentiviral vectors.

Authors:  N Klages; R Zufferey; D Trono
Journal:  Mol Ther       Date:  2000-08       Impact factor: 11.454

2.  Production of retroviral vectors for clinical use.

Authors:  Kenneth Cornetta; Lilith Reeves; Scott Cross
Journal:  Methods Mol Biol       Date:  2008

3.  Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells.

Authors:  Mingjie Li; John J Rossi
Journal:  Methods Mol Biol       Date:  2008

Review 4.  Lentiviral vectors in clinical trials: Current status.

Authors:  Jenice D'Costa; S Gary Mansfield; Laurent M Humeau
Journal:  Curr Opin Mol Ther       Date:  2009-10

5.  Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

Authors:  L Naldini; U Blömer; F H Gage; D Trono; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

7.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.

Authors:  J Reiser; G Harmison; S Kluepfel-Stahl; R O Brady; S Karlsson; M Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.

Authors:  David L DiGiusto; Amrita Krishnan; Lijing Li; Haitang Li; Shirley Li; Anitha Rao; Shu Mi; Priscilla Yam; Sherri Stinson; Michael Kalos; Joseph Alvarnas; Simon F Lacey; Jiing-Kuan Yee; Mingjie Li; Larry Couture; David Hsu; Stephen J Forman; John J Rossi; John A Zaia
Journal:  Sci Transl Med       Date:  2010-06-16       Impact factor: 17.956

9.  Design of HIV vectors for efficient gene delivery into human hematopoietic cells.

Authors:  Priscilla Y Yam; Shulian Li; Jerry Wu; Jun Hu; John A Zaia; Jiing-Kuan Yee
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

10.  Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.

Authors:  Yajin Ni; Susan Sun; Ibe Oparaocha; Laurent Humeau; Brian Davis; Reuben Cohen; Gwendolyn Binder; Yung-Nien Chang; Vladimir Slepushkin; Boro Dropulic
Journal:  J Gene Med       Date:  2005-06       Impact factor: 4.565
View more
  31 in total

Review 1.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

Review 2.  Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies.

Authors:  X Wang; I Rivière
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

3.  Real-time transfer of lentiviral particles by producer cells using an engineered coculture system.

Authors:  Lauren M Timmins; Riya S Patel; Matthew S Teryek; Biju Parekkadan
Journal:  Cytotechnology       Date:  2019-09-12       Impact factor: 2.058

4.  The Superiority of Sucrose Cushion Centrifugation to Ultrafiltration and PEGylation in Generating High-Titer Lentivirus Particles and Transducing Stem Cells with Enhanced Efficiency.

Authors:  Mahdi Eskandarian Boroujeni; Mossa Gardaneh
Journal:  Mol Biotechnol       Date:  2018-03       Impact factor: 2.695

5.  Manufacture of Third-Generation Lentivirus for Preclinical Use, with Process Development Considerations for Translation to Good Manufacturing Practice.

Authors:  Carolina Gándara; Valerie Affleck; Elizabeth Ann Stoll
Journal:  Hum Gene Ther Methods       Date:  2018-01-24       Impact factor: 2.396

Review 6.  The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma.

Authors:  Daniel Feinberg; Barry Paul; Yubin Kang
Journal:  Cell Immunol       Date:  2019-08-13       Impact factor: 4.868

7.  Lentivirus Manufacturing Process for Primary T-Cell Biofactory Production.

Authors:  Harikrishnan Radhakrishnan; Harold S Javitz; Parijat Bhatnagar
Journal:  Adv Biosyst       Date:  2020-05-10

8.  Development of isoporous microslit silicon nitride membranes for sterile filtration applications.

Authors:  Evan Wright; Joshua J Miller; Matthew Csordas; Andrew R Gosselin; Jared A Carter; James L McGrath; David R Latulippe; James A Roussie
Journal:  Biotechnol Bioeng       Date:  2019-12-18       Impact factor: 4.530

Review 9.  Selecting a Cell Engineering Methodology During Cell Therapy Product Development.

Authors:  Lauren M Timmins; Alexandra M Burr; Kristina Carroll; Robert Keefe; Matthew Teryek; Louis J Cantolupo; Johannes C M van der Loo; Thomas R J Heathman; Adam Gormley; David Smith; Biju Parekkadan
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

10.  Rationally Designed Transgene-Encoded Cell-Surface Polypeptide Tag for Multiplexed Programming of CAR T-cell Synthetic Outputs.

Authors:  Adam J Johnson; Jia Wei; James M Rosser; Annette Künkele; Cindy A Chang; Aquene N Reid; Michael C Jensen
Journal:  Cancer Immunol Res       Date:  2021-07-09       Impact factor: 11.151
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.